Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?
There are still plenty of unknowns related to Axsome’s FDA filing.
Mindfully Curated
There are still plenty of unknowns related to Axsome’s FDA filing.
Here’s how the cloud-based database specialist is impressing investors.
These companies offer a compelling combo of yield and upside potential.
Despite already being fined earlier this year, Alibaba fell even more last month on continued concerns over the regulation of China’s tech sector.
These August headlines can help investors build a strong stock portfolio.
The pharma giant recently received approval to market Forxiga as a treatment for chronic kidney disease patients in Japan.
This innovative company chose a non-traditional route to the public markets.
The world’s second-largest cryptocurrency has way more use cases than Bitcoin and may be a better long-term investment.
The cloud-based services company turns in another solid quarter.
This is an entirely different company than it was just two years ago.
Three investment ideas that won’t get stuck on the launching pad.
There are differences of opinion on this hot-button topic.
Becoming a retirement millionaire is possible if you can follow this five-step plan.
The reason it’s a long shot might surprise you.
When a founder-led company is profitably chasing a huge market and having early success, the stock is worth a closer look.
The math works if everything goes right.
Could one of them work for you?
Don’t need the money right away? This strategy is perfect for you.
It doesn’t always pay to hold off on filing for benefits.